Quality
Quality, grounded in evidence.
We organize available peptide, manufacturer, facility, batch, and document information according to source, scope, status, and date — spanning United States Food and Drug Administration (FDA) inspection context, available Current Good Manufacturing Practice (CGMP) evidence, and applicable International Organization for Standardization/International Electrotechnical Commission (ISO/IEC) 17025:2017 laboratory accreditation.
COA Verification
Verify a Certificate of Analysis.
Enter the COA or document reference and the batch or lot number shown on your Certificate of Analysis. A match confirms that the identifiers correspond to an available RED BioMed record.
The COA reference and batch or lot number are normally printed near the document title, product information, sample information, or batch-information section.
Public verification returns limited status information only. Access to the full document requires organization qualification and document-specific authorization.
What COA verification means.
A confirmed match tells you that the COA and batch identifiers correspond to an available RED BioMed record. The information applies only to the identified document, peptide, batch, source, scope, status, and date.
A match does not establish regulatory approval, clinical suitability, safety, efficacy, or the authenticity of material obtained outside a documented supply pathway.
Our Standards
How we approach available information.
- Source
- Identify where the information originated and who issued it.
- Scope
- Determine the organization, facility, peptide, batch, test, or activity to which it applies.
- Status
- Record whether the information is current, pending review, superseded, expired, or not independently confirmed.
- Context
- Consider intended use, destination market, project stage, and material limitations.
FDA inspection-history review
Inspection history evaluated by entity, facility, scope, and date.
Our partner-review process may consider documented United States Food and Drug Administration (FDA) inspection histories for relevant manufacturing entities and facilities.
Inspection information is reviewed by legal entity, facility, applicable scope, inspection date, and available status. An inspection history is related to, but not interchangeable with, current compliance with applicable Current Good Manufacturing Practice (CGMP) requirements, and does not, by itself, constitute approval of a manufacturer, facility, peptide, production line, or batch.
A company-level credential or past inspection does not automatically establish the current regulatory status of every facility, peptide, production line, batch, or market.
Current Good Manufacturing Practice
Quality-system evidence, evaluated as evidence.
We evaluate available manufacturing and quality-system evidence relevant to applicable Current Good Manufacturing Practice (CGMP) requirements — such as quality-system documentation, standard operating procedures, batch records, change-control information, and internal or third-party audit outcomes where these are shared.
CGMP applicability, expectations, and scope vary by product type, jurisdiction, and stage of manufacture. Available evidence is reviewed by facility, applicable scope, and date, and is treated as informational input to a broader qualification process rather than a permanent status.
A past inspection outcome, a written quality manual, or an internal statement of CGMP compliance is not, by itself, proof of current compliance and is not a product approval. We do not present inspection history or quality-system documentation as certification, facility approval, product approval, or proof of permanent compliance.
Independent laboratory review
Accreditation considered within the applicable testing scope.
Applicable testing may be coordinated through independent laboratories accredited to International Organization for Standardization/International Electrotechnical Commission (ISO/IEC) 17025:2017 — General requirements for the competence of testing and calibration laboratories.
Accreditation is reviewed by laboratory, accreditation body, certificate status, accredited scope, method where applicable, and date. A laboratory’s accreditation does not mean that every test it performs falls within its accredited scope.
Laboratory accreditation and analytical records support evidence review but do not independently establish product approval, regulatory compliance, clinical suitability, or guaranteed product quality.
Information that may be available.
- Manufacturer and Facility
- Entity, facility, quality-system, registration, audit, certification, and inspection information where available.
- Peptide and Technical
- Identity, specifications, analytical information, manufacturing standards, storage, stability, impurity, and packaging information where available.
- Batch and Records
- Certificate of Analysis, batch identification, applicable testing, laboratory, release, conformity, and traceability records where available.
Available records vary by partner, peptide, batch, intended use, destination market, authorization, and stage of review.
Inspection, quality-system, and accreditation information is evaluated by entity, facility or laboratory, applicable scope, status, and date. These records do not constitute product approval or guarantee current compliance, quality, regulatory status, or market authorization.
Questions about a specific record?
We coordinate Certificate of Analysis review directly with qualified organizations. Contact our coordination team with the Certificate of Analysis and batch identifiers shown on your document.
Email: info@redbiomed.com